BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schöneberg T, Liebscher I. Mutations in G Protein-Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches. Pharmacol Rev 2021;73:89-119. [PMID: 33219147 DOI: 10.1124/pharmrev.120.000011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Mkaouar R, Abdallah LCB, Naouali C, Lahbib S, Turki Z, Elouej S, Bouyacoub Y, Somai M, Mcelreavey K, Bashamboo A, Abdelhak S, Messaoud O. Oligogenic Inheritance Underlying Incomplete Penetrance of PROKR2 Mutations in Hypogonadotropic Hypogonadism. Front Genet 2021;12:665174. [PMID: 34539727 DOI: 10.3389/fgene.2021.665174] [Reference Citation Analysis]
2 Ma N, Nivedha AK, Vaidehi N. Allosteric communication regulates ligand‐specific GPCR activity. FEBS J 2021;288:2502-12. [DOI: 10.1111/febs.15826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ma X, Segura MA, Zarzycka B, Vischer HF, Leurs R. Analysis of Missense Variants in the Human Histamine Receptor Family Reveals Increased Constitutive Activity of E4106.30×30K Variant in the Histamine H1 Receptor. Int J Mol Sci 2021;22:3702. [PMID: 33918180 DOI: 10.3390/ijms22073702] [Reference Citation Analysis]
4 Liu L, Fan Z, Rovira X, Xue L, Roux S, Brabet I, Xin M, Pin JP, Rondard P, Liu J. Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface. Elife 2021;10:e70188. [PMID: 34866572 DOI: 10.7554/eLife.70188] [Reference Citation Analysis]
5 Apgar TL, Sanders CR. Compendium of causative genes and their encoded proteins for common monogenic disorders. Protein Sci 2021. [PMID: 34515378 DOI: 10.1002/pro.4183] [Reference Citation Analysis]
6 Gonçalves-Monteiro S, Ribeiro-Oliveira R, Vieira-Rocha MS, Vojtek M, Sousa JB, Diniz C. Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases. Pharmaceuticals (Basel) 2021;14:439. [PMID: 34066915 DOI: 10.3390/ph14050439] [Reference Citation Analysis]
7 Tanaka T, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Sano M, Asano T, Kaneko MK, Kato Y. Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother 2021;40:65-70. [PMID: 33900818 DOI: 10.1089/mab.2021.0005] [Reference Citation Analysis]
8 Krishna Deepak RNV, Verma RK, Hartono YD, Yew WS, Fan H. Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery. Pharmaceuticals (Basel) 2021;15:12. [PMID: 35056070 DOI: 10.3390/ph15010012] [Reference Citation Analysis]
9 Wittlake A, Prömel S, Schöneberg T. The Evolutionary History of Vertebrate Adhesion GPCRs and Its Implication on Their Classification. Int J Mol Sci 2021;22:11803. [PMID: 34769233 DOI: 10.3390/ijms222111803] [Reference Citation Analysis]
10 Takei J, Suzuki H, Asano T, Tanaka T, Kaneko MK, Kato Y. Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-Terminal Peptide Immunization. Monoclon Antib Immunodiagn Immunother 2022;41:87-93. [PMID: 35471046 DOI: 10.1089/mab.2021.0064] [Reference Citation Analysis]
11 Beeraka NM, Vikram PRH, Greeshma MV, Uthaiah CA, Huria T, Liu J, Kumar P, Nikolenko VN, Bulygin KV, Sinelnikov MY, Sukocheva O, Fan R. Recent Investigations on Neurotransmitters' Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies-Glia Dynamics in Stem Cell Therapy. Mol Neurobiol 2022. [PMID: 35041139 DOI: 10.1007/s12035-021-02700-7] [Reference Citation Analysis]
12 Tanaka T, Li G, Asano T, Saito M, Kaneko MK, Suzuki H, Kato Y. Development of a Novel Anti-Mouse CCR2 Monoclonal Antibody (C2Mab-6) by N-Terminal Peptide Immunization. Monoclon Antib Immunodiagn Immunother 2022. [PMID: 35377242 DOI: 10.1089/mab.2021.0063] [Reference Citation Analysis]
13 Lindquist P, Madsen JS, Bräuner-Osborne H, Rosenkilde MM, Hauser AS. Mutational Landscape of the Proglucagon-Derived Peptides. Front Endocrinol (Lausanne) 2021;12:698511. [PMID: 34220721 DOI: 10.3389/fendo.2021.698511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 van der Velden WJC, Lindquist P, Madsen JS, Stassen RHMJ, Wewer Albrechtsen NJ, Holst JJ, Hauser AS, Rosenkilde MM. Molecular and in vivo phenotyping of missense variants of the human glucagon receptor. J Biol Chem 2021;:101413. [PMID: 34801547 DOI: 10.1016/j.jbc.2021.101413] [Reference Citation Analysis]
15 Kaczmarek I, Suchý T, Prömel S, Schöneberg T, Liebscher I, Thor D. The relevance of adhesion G protein-coupled receptors in metabolic functions. Biol Chem 2021. [PMID: 34218541 DOI: 10.1515/hsz-2021-0146] [Reference Citation Analysis]
16 Hauser AS, Kooistra AJ, Munk C, Heydenreich FM, Veprintsev DB, Bouvier M, Babu MM, Gloriam DE. GPCR activation mechanisms across classes and macro/microscales. Nat Struct Mol Biol 2021;28:879-88. [PMID: 34759375 DOI: 10.1038/s41594-021-00674-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ahn MB. Extrathyroidal Manifestations of Persistent Sporadic Non-Autoimmune Hyperthyroidism in a 6-Year-Old Boy: A Case Report. Life (Basel) 2021;11:713. [PMID: 34357084 DOI: 10.3390/life11070713] [Reference Citation Analysis]